Skip to main content

Table 2 Comparison of immune and nutritional parameters

From: Efficacy of immunonutritional supplement after neoadjuvant chemotherapy in patients with esophageal cancer

Items

Before matching

After matching

Control group (n = 103)

EIN group (n = 21)

p value

Control group (n = 42)

EIN group (n = 21)

p value

IgM

 PRD-7

1.27 ± 0.42

1.26 ± 0.42

0.926

1.30 ± 0.40

1.26 ± 0.42

0.662

 PRD-1

1.29 ± 0.50

1.28 ± 0.53

0.962

1.27 ± 0.50

1.28 ± 0.53

0.896

 POD-1

1.03 ± 0.32

0.99 ± 0.50

0.643

1.05 ± 0.37

0.99 ± 0.50

0.619

 POD-7

1.5 ± 0.35

1.18 ± 0.33

0.001

1.43 ± 0.33

1.18 ± 0.33

0.007

IgA

 PRD-7

2.21 ± 0.55

2.20 ± 0.58

0.904

2.21 ± 0.55

2.20 ± 0.58

0.880

 PRD-1

2.23 ± 0.67

2.65 ± 0.72

0.109

2.48 ± 0.620

2.65 ± 0.72

0.356

 POD-1

1.94 ± 0.59

1.93 ± 0.62

0.934

1.92 ± 0.70

1.93 ± 0.62

0.991

 POD-7

2.13 ± 0.65

2.44 ± 0.65

0.045

2.02 ± 0.65

2.44 ± 0.65

0.017

IgG

 PRD-7

11.65 ± 2.5

11.28 ± 2.53

0.538

11.39 ± 2.51

11.28 ± 2.53

0.866

 PRD-1

12.23 ± 2.08

12.72 ± 1.93

0.320

12.31 ± 1.98

12.72 ± 1.93

0.432

 POD-1

10.48 ± 1.89

10.78 ± 1.7

0.497

10.53 ± 1.77

10.78 ± 1.7

0.591

 POD-7

11.02 ± 1.81

11.90 ± 1.77

0.042

11.43 ± 1.76

11.90 ± 1.77

0.315

ALB

 PRD-7

34.75 ± 3.99

33.95 ± 4.12

0.407

35.67 ± 4.52

33.95 ± 4.12

0.148

 PRD-1

40.19 ± 3.96

39.99 ± 4.64

0.837

41.16 ± 4.01

39.99 ± 4.64

0.303

 POD-1

33.42 ± 3.46

33.55 ± 3.33

0.876

33.54 ± 4.09

33.55 ± 3.33

0.991

 POD-7

35.14 ± 4.18

35.11 ± 3.60

0.981

33.926 ± 4.58

35.11 ± 3.60

0.303

  1. EIN, enteral immunonutrition, IgM, immunoglobulin M. IgA, immunoglobulin A, IgG, immunoglobulin G, ALB, albumin. PRD, preoperative days. POD, postoperative days